BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 2569318)

  • 1. Different affinities of alpha 2-agonists for imidazoline and alpha 2-adrenergic receptors.
    Coupry I; Lachaud V; Podevin RA; Koenig E; Parini A
    Am J Hypertens; 1989 Jun; 2(6 Pt 1):468-70. PubMed ID: 2569318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Selectivity of alpha 2-adrenergic agonists for the imidazoline-guanidine and alpha 2-adrenergic receptors].
    Lachaud V; Coupry I; Podevin RA; Koenig E; Parini A
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1135-7. PubMed ID: 2573323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interaction of rilmenidine with renal imidazoline-guanidine sites].
    Lachaud V; Bidet M; Coupry I; Podevin RA; Poujeol P; Parini A
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():15-8. PubMed ID: 2576516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
    Gargalidis-Moudanos C; Parini A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imidazoline-guanidinium and alpha 2-adrenergic binding sites in basolateral membranes from human kidney.
    Lachaud-Pettiti V; Podevin RA; Chrétien Y; Parini A
    Eur J Pharmacol; 1991 Jan; 206(1):23-31. PubMed ID: 1648494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of clonidine and rilmenidine with imidazoline-preferring receptors.
    Lachaud V; Coupry I; Podevin RA; Dausse JP; Koenig E; Parini A
    J Hypertens Suppl; 1988 Dec; 6(4):S511-3. PubMed ID: 3241245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of binding sites for [3H]-idazoxan, [3H]-P-aminoclonidine and [3H]-rauwolscine in the kidney of the dog.
    Evans RG; Haynes JM
    Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):649-58. PubMed ID: 7813124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
    Renouard A; Widdowson PS; Cordi A
    Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
    Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for imidazoline binding sites in basolateral membranes from rabbit kidney.
    Coupry I; Podevin RA; Dausse JP; Parini A
    Biochem Biophys Res Commun; 1987 Sep; 147(3):1055-60. PubMed ID: 2889454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imidazoline receptors in rat liver cells: a novel receptor or a subtype of alpha 2-adrenoceptors?
    Zonnenchein R; Diamant S; Atlas D
    Eur J Pharmacol; 1990 Nov; 190(1-2):203-15. PubMed ID: 1981751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of nonadrenergic [3H]rilmenidine binding in rat brain and kidney.
    King PR; Suzuki S; Louis WJ; Gundlach AL
    Ann N Y Acad Sci; 1995 Jul; 763():194-207. PubMed ID: 7677331
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of imidazoline-guanidinium receptive sites in renal medulla from human kidney.
    Lachaud V; Limon I; Tesson F; Coupry I; Parini A
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):69S-71S. PubMed ID: 1350730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of imidazoline sites in rabbit kidney.
    Hamilton CA; Jardine E; Reid JL
    Eur J Pharmacol; 1993 Oct; 243(1):95-7. PubMed ID: 7902815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive features of rilmenidine possibly related to its selectivity for imidazoline receptors.
    Harron DW
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):91S-98S. PubMed ID: 1350732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High affinity binding of 3H rauwolscine and 3H RX781094 to alpha 2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes.
    Convents A; Convents D; De Backer JP; De Keyser J; Vauquelin G
    Biochem Pharmacol; 1989 Feb; 38(3):455-63. PubMed ID: 2563652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
    Pinthong D; Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Jun; 115(4):689-95. PubMed ID: 7582492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.